Industry Background:
The Stable isotope labeling contains the usage of non-radioactive isotopes that can act as a tracer used to model several biochemical and chemical systems. The chosen isotope can act as a label on that compound that can be recognized through mass spectrometry (MS) and nuclear magnetic resonance (NMR). Some of the most common stable isotopes are 13C, 2H, and 15N, which can further be produced into NMR solvents, nucleic acids, amino acids, lipids, common metabolites, and cell growth media.
According to AMA Research, the market for Stable Isotopes Labelled Compounds is expected to register a CAGR of 2.93% during the forecast period to 2027. This growth is primarily driven by Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector
.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Forecast Period | 2022-2027 |
Historical Period | 2017-2021 |
Unit | Value (USD Million) |
Key Companies in Study | Cambridge Isotope Laboratories, Inc. (United States), Merck KGaA (Germany), Urenco Limited (United Kingdom), Isosciences, LLC (An Mdp Chemicals Company) (United States), Medical Isotopes, Inc. (United States), Omicron Biochemicals, Inc. (United States), Nordion Inc. (A Sterigenics International LLC Company) (Canada), Trace Sciences International (Canada), Alsachim (France) and Taiyo Nippon Sanso Corporation (Japan) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Biotechnology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Cambridge Isotope Laboratories, Inc. (United States), Merck KGaA (Germany), Urenco Limited (United Kingdom), Isosciences, LLC (An Mdp Chemicals Company) (United States), Medical Isotopes, Inc. (United States), Omicron Biochemicals, Inc. (United States), Nordion Inc. (A Sterigenics International LLC Company) (Canada), Trace Sciences International (Canada), Alsachim (France) and Taiyo Nippon Sanso Corporation (Japan) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
Market Drivers
- Increase In R&D Activities In The Pharmaceutical And Biotechnology Sector
- Growing Proteomics Research
- A Rising Prevalence Of Cancer
- Favorable Regulatory scenario
Market Trend
Restraints
- High Cost of Stable Isotope-Labeled Compounds
Opportunities
Rising Investments in Pharmaceutical R&D in Emerging Markets
Challenges
Dearth of Skilled Professionals
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Stable Isotopes Labelled Compounds Study Sheds Light on
The Stable Isotopes Labelled Compounds Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Stable Isotopes Labelled Compounds industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Stable Isotopes Labelled Compounds industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.